Search

Search Constraints

You searched for: Author/Creator Simard, Christopher

Search Results

1. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Issue 10212 (23rd November 2019)

2. Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor. Issue 8 (10th May 2018)

3. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Issue 10212 (23rd November 2019)